Se espera que el mercado del tratamiento de la anafilaxia alcance los 4.787,66 millones de dólares en 2028 desde los 2.664,66 millones de dólares en 2021; Se estima que crecerá a una tasa compuesta anual del 8,7% durante 2021-2028.
La anafilaxia es una reacción alérgica que puede provocar además una afección mortal conocida como shock anafiláctico. La anafilaxia ocurre cuando el cuerpo del paciente reacciona a una sustancia extraña y produce una gran cantidad de histamina que desencadena una respuesta inflamatoria. Según la Asthma and Allergy Foundation of America (AAFA), en Estados Unidos, cada año se producen alrededor de 200.000 visitas al hospital debido a alergias alimentarias. El crecimiento del mercado del tratamiento de la anafilaxia se atribuye a factores como la creciente incidencia de la anafilaxia y las recientes aprobaciones de epinefrina. Sin embargo, la escasa accesibilidad a los autoinyectores de epinefrina en los países de bajos ingresos obstaculiza el crecimiento del mercado.
regiones lucrativas para el mercado del tratamiento de la anafilaxia
< h3>Perspectivas del mercado
Creciente incidencia de anafilaxia
La anafilaxia es una reacción alérgica grave y potencialmente mortal causada por la vulnerabilidad a los alérgenos (alimentos, picaduras de insectos o medicamentos). ) identificado como no-yo por un cuerpo humano. Las indicaciones típicas de esta afección incluyen dificultades para tragar y respirar, enrojecimiento y picazón de la piel, frecuencia cardíaca acelerada, sibilancias, frecuencia respiratoria rápida y disminución de la presión arterial. La incidencia de anafilaxia está aumentando en todo el mundo. Según el Instituto Nacional para la Excelencia en la Salud y la Atención (NICE), la anafilaxia causa más de 20 muertes cada año en el Reino Unido. Según datos de la Academia Europea de Alergia e Inmunología Clínica, aproximadamente 150 millones de europeos padecen enfermedades alérgicas crónicas cada año. Por lo tanto, la creciente incidencia de alergias está provocando un aumento de los casos de anafilaxia. Además, según los datos sobre alergias del American College of Allergy, Asthma & En Inmunología, más de 50 millones de personas experimentan diferentes tipos de alergias cada año.
1: el 15 % de la población estadounidense corre el riesgo de sufrir una reacción anafiláctica cuando se expone a uno o más alérgenos, y hasta el 1 % de estos pacientes mueren. debido a anafilaxia. La afección provoca aproximadamente 1.500 muertes por año en los EE. UU.; También enumera las alergias como la sexta circunstancia de enfermedad crónica. Además, según la Fundación Estadounidense de Asma y Alergia (AAFA), debido al aumento de reacciones alérgicas a los alimentos, ha aumentado el número de visitas al hospital. Las alergias alimentarias son la causa de más de 200.000 visitas a las salas de urgencias (ER) al año. Investigación y análisis de alergias alimentarias La educación afirma que más de 32 millones de estadounidenses viven con alergias alimentarias potencialmente mortales. Debido a la creciente prevalencia de las alergias, la carga económica para los sistemas sanitarios de muchos países está aumentando. Por ejemplo, según Allergy Facts, el coste anual de gestionar los casos de alergias es de más de 18 mil millones de dólares en Estados Unidos. Por lo tanto, la creciente incidencia de la anafilaxia está impulsando el crecimiento del mercado.
Información basada en el tipo de medicamento
Según el tipo de medicamento, la anafilaxia El mercado de tratamientos se segmenta en epinefrina, antihistamínicos, esteroides, betaagonistas y otros. El segmento de epinefrina tuvo la mayor participación de mercado en 2020 y se prevé que registre la CAGR más alta del mercado durante el período de pronóstico.
Mercado de tratamiento de anafilaxia, por medicamento Escriba: 2020 y 2028
Perspectivas basadas en la ruta de administración
Basado en la ruta de administración, El mercado del tratamiento de la anafilaxia se segmenta en oral, parenteral y otros. El segmento parenteral tuvo la mayor participación del mercado en 2020, mientras que se prevé que el segmento oral registre la CAGR más alta del 8,9% en el mercado durante el período previsto.
Información basada en el tipo de alergia
Según el tipo de alergia, el mercado del tratamiento de la anafilaxia se segmenta en alergia alimentaria, medicamentos, picaduras de insectos y otros. . El segmento de alergias alimentarias tuvo la mayor participación del mercado en 2020 y se estima que registrará la CAGR más alta del mercado durante el período de pronóstico.
Información basada en el canal de distribución
Según el canal de distribución, el mercado del tratamiento de la anafilaxia se segmenta en farmacias hospitalarias, ventas minoristas, correo de farmacias y otros. El segmento de ventas minoristas tuvo la mayor participación del mercado en 2020 y se estima que registrará la CAGR más alta del mercado durante el período de pronóstico.
Perspectivas estratégicas
Los lanzamientos y aprobaciones de productos son estrategias comúnmente adoptadas por las empresas para expandir su presencia global y sus carteras de productos. Además, los actores del mercado del tratamiento de la anafilaxia se centran en la estrategia de colaboración para ampliar su clientela, lo que, a su vez, les permite mantener su marca a nivel mundial.
Mercado del tratamiento de la anafilaxia - por tipo de medicamento
- Epinefrina
- Antihistamínicos
- Esteroides
- Betagonistas
- Otros
Mercado de tratamiento de anafilaxia: por vía de administración
- Oral
- Parenteral
- Otros
Mercado de tratamiento de anafilaxia – ndash; por tipo de alergia
- Alergia alimentaria
- Medicamentos
- Picaduras de insectos
- Otros
Mercado del tratamiento de la anafilaxia: por canal de distribución
- Farmacias hospitalarias
- Ventas minoristas
- Otros
Mercado de tratamiento de anafilaxia: por Geografía
- América del Norte
- Estados Unidos
- Canadá
- México
< li>Europa - Francia
- Alemania
- Italia
- Reino Unido
- España
- Resto de Europa
- Asia Pacífico (APAC)
- China
- India
- Corea del Sur
- Japón
- Australia
- Resto de Asia Pacífico
- Medio Oriente y África (MEA)
- Sudáfrica
- Arabia Saudita
- EAU
- Resto de Oriente Medio y África
- Sur y Centroamérica (SCAM)
- Brasil
- Argentina
- Resto de Sudamérica y Centroamérica
Perfiles de la empresa
- Amneal Pharmaceuticals Inc.
- Bioprojet
- Mylan NV
- Adamis Pharmaceutical Corporation
- Abbott
- Pfizer Inc.
- Glaxosmithkline Plc.
- Merck And Co., Inc.
- Teva Pharmaceutical Industries Ltd.
- ALK-ABELL
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Anaphylaxis is an allergic reaction that can further lead to a fatal condition known as anaphylactic shock. Anaphylaxis occurs when the patient's body reacts to a foreign substance and produces a high amount of histamine that triggers an inflammatory response.
The growth of the anaphylaxis treatment market is attributed to the factors such as rising incidence of anaphylaxis, and recent approvals of epinephrine. Moreover, rise in cases of allergies post administration of covid-19 vaccines is also favoring the growth of the market
The anaphylaxis treatment market majorly consists of the players such as Amneal Pharmaceuticals Inc., Bioprojet, Mylan N.V., Adamis Pharmaceutical Corporation, Abbott, Pfizer Inc., Glaxosmithkline Plc., Merck And Co. Inc., Teva Pharmaceutical Industries Ltd., ALK-ABELLó among others.
The List of Companies - Anaphylaxis Treatment Market
- Amneal Pharmaceuticals Inc.
- Bioprojet
- Mylan N.V.
- Adamis Pharmaceutical Corporation
- Abbott
- Pfizer Inc.
- Glaxosmithkline Plc.,
- Merck And Co., Inc.
- Teva Pharmaceutical Industries Ltd.
- ALK-ABELLó
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Jun 2021
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2021
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jun 2021
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jun 2021
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2021
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2021
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Jun 2021
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Jun 2021
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)